Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.26 -0.9%	$1.86	$0.76 ▼ $2.73	$85.41M	1.31	85,906 shs	39,380 shs
CATX Perspective Therapeutics	$4.20 +1.7%	$3.25	$1.60 ▼ $16.55	$311.76M	1.18	1.09 million shs	924,507 shs
DRTS Alpha Tau Medical	$3.04 -0.7%	$3.03	$1.93 ▼ $4.39	$257.85M	0.99	49,495 shs	35,232 shs
NNOX Nano-X Imaging	$5.14 +1.4%	$5.24	$3.75 ▼ $11.00	$296.99M	1.96	1.73 million shs	1.63 million shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	+7.62%	+13.00%	+130.61%	+67.41%
CATX Perspective Therapeutics	0.00%	+5.53%	+21.39%	+118.75%	-66.77%
DRTS Alpha Tau Medical	0.00%	-0.65%	+4.83%	+15.15%	+44.76%
NNOX Nano-X Imaging	0.00%	+1.58%	+3.01%	+8.21%	-32.72%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APYX Apyx Medical	1.8494 of 5 stars	0.0	4.0	4.2	0.0	1.7	0.6
CATX Perspective Therapeutics	2.4135 of 5 stars	4.6	1.0	0.0	2.0	0.8	0.0
DRTS Alpha Tau Medical	2.454 of 5 stars	3.5	5.0	0.0	0.6	1.7	0.0
NNOX Nano-X Imaging	2.2413 of 5 stars	3.6	2.0	0.0	2.9	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.67	Moderate Buy	N/A	N/A
CATX Perspective Therapeutics	3.18	Buy	$12.56	198.94% Upside
DRTS Alpha Tau Medical	3.00	Buy	$8.00	163.16% Upside
NNOX Nano-X Imaging	3.25	Buy	$9.50	84.82% Upside

Current Analyst Ratings Breakdown

Latest APYX, NNOX, CATX, and DRTS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/14/2025	NNOX Nano-X Imaging	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/12/2025	CATX Perspective Therapeutics	Lifesci Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/23/2025	CATX Perspective Therapeutics	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$9.00 ➝ $12.00
6/23/2025	CATX Perspective Therapeutics	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$11.00
6/6/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
6/3/2025	CATX Perspective Therapeutics	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Outperform ➝ Moderate Buy	$15.00 ➝ $16.00
5/23/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $10.00
5/22/2025	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/14/2025	CATX Perspective Therapeutics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$10.00 ➝ $8.00
5/13/2025	CATX Perspective Therapeutics	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform	$11.00
4/29/2025	DRTS Alpha Tau Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$9.00 ➝ $9.00

(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$48.10M	1.78	N/A	N/A	$0.38 per share	5.95
CATX Perspective Therapeutics	N/A	N/A	N/A	N/A	$2.67 per share	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.89 per share	N/A
NNOX Nano-X Imaging	$11.28M	26.33	N/A	N/A	$3.27 per share	1.57

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$23.46M	-$0.55	N/A	N/A	N/A	-42.37%	-156.85%	-31.92%	8/6/2025 (Estimated)
CATX Perspective Therapeutics	-$46.51M	N/A	0.00	N/A	N/A	-4,096.66%	-27.40%	-23.16%	8/13/2025 (Estimated)
DRTS Alpha Tau Medical	-$31.75M	-$0.46	N/A	N/A	N/A	N/A	-49.48%	-36.69%	8/13/2025 (Estimated)
NNOX Nano-X Imaging	-$53.52M	-$0.90	N/A	N/A	N/A	-472.19%	-30.92%	-27.73%	8/19/2025 (Estimated)

Latest APYX, NNOX, CATX, and DRTS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	N/A	CATX Perspective Therapeutics	-$0.30	N/A	N/A	N/A	$0.17 million	N/A
8/13/2025	Q2 2025	DRTS Alpha Tau Medical	-$0.12	N/A	N/A	N/A	N/A	N/A
5/22/2025	Q1 2025	NNOX Nano-X Imaging	-$0.23	-$0.21	+$0.02	-$0.21	$3.98 million	$3.00 million
5/19/2025	Q1 2025	DRTS Alpha Tau Medical	-$0.14	-$0.12	+$0.02	-$0.12	$0.03 million	N/A
5/8/2025	Q1 2025	APYX Apyx Medical	-$0.13	-$0.10	+$0.03	-$0.10	$9.39 million	$9.43 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
CATX Perspective Therapeutics	N/A	N/A	N/A	N/A	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	3.21	5.45	4.64
CATX Perspective Therapeutics	N/A	9.60	9.60
DRTS Alpha Tau Medical	0.10	5.81	5.81
NNOX Nano-X Imaging	N/A	5.30	5.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
CATX Perspective Therapeutics	54.66%
DRTS Alpha Tau Medical	2.65%
NNOX Nano-X Imaging	21.49%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.20%
CATX Perspective Therapeutics	3.72%
DRTS Alpha Tau Medical	39.50%
NNOX Nano-X Imaging	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	270	37.79 million	32.05 million	Optionable
CATX Perspective Therapeutics	70	74.23 million	65.21 million	Optionable
DRTS Alpha Tau Medical	80	84.82 million	51.32 million	No Data
NNOX Nano-X Imaging	190	57.78 million	N/A	Optionable

APYX, NNOX, CATX, and DRTS Headlines

Recent News About These Companies

Nano-X Imaging (NASDAQ:NNOX) Stock Rating Upgraded by LADENBURG THALM/SH SH

July 16, 2025 | marketbeat.com

Nanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC

July 1, 2025 | globenewswire.com

Nanox Imaging to Present at the Investor Summit Virtual on June 10, 2025

June 9, 2025 | accessnewswire.comA

Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment

June 5, 2025 | globenewswire.com

Nanox to Participate in Sidoti Small Cap Conference

June 3, 2025 | globenewswire.com

What Does The Future Hold For Nano-X Imaging Ltd. (NASDAQ:NNOX)? These Analysts Have Been Cutting Their Estimates

May 27, 2025 | finance.yahoo.com

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q1 2025 Earnings Call Transcript

May 24, 2025 | insidermonkey.com

Nano-X Imaging price target lowered to $7 from $9 at Alliance Global Partners

May 23, 2025 | finance.yahoo.com

Nano X Imaging Ltd (NNOX) Q1 2025: Everything You Need To Know Ahead Of Earnings

May 23, 2025 | finance.yahoo.com

Nano-X Imaging Reports Q1 2025 Financial Results and Growth

May 22, 2025 | tipranks.com

Nano-X Imaging Ltd. Earnings Call: Growth Amid Challenges

May 22, 2025 | tipranks.com

Nano-X Imaging Ltd. (NNOX) Q1 2025 Earnings Call Transcript

May 22, 2025 | seekingalpha.com

Nanox Announces First Quarter 2025 Financial Results and Provides Business Updates

May 22, 2025 | finance.yahoo.com

Nano-X Imaging: Still Too Early To Invest

May 9, 2025 | seekingalpha.com

Nanox to Report First Quarter 2025 Financial Results on May 22, 2025

May 8, 2025 | globenewswire.com

Nanox New Imaging System Receives FDA Clearance

April 21, 2025 | finance.yahoo.com

Nano X Imaging Ltd (NNOX) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Financial ...

April 21, 2025 | finance.yahoo.com

Nano-X Imaging receives FDA clearance for general use of Nanox.ARC X

April 17, 2025 | markets.businessinsider.com

Nanox Climbs on Releasing Imaging System

April 17, 2025 | baystreet.ca

Why Nano-X Imaging Stock Soared Today

April 17, 2025 | fool.com

Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X

April 17, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX, NNOX, CATX, and DRTS Company Descriptions

Apyx Medical NASDAQ:APYX

$2.26 -0.02 (-0.88%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$2.27 +0.01 (+0.44%)

As of 07/18/2025 04:09 PM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Perspective Therapeutics NYSE:CATX

$4.20 +0.07 (+1.69%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$4.34 +0.14 (+3.33%)

As of 06:26 AM Eastern

Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Alpha Tau Medical NASDAQ:DRTS

$3.04 -0.02 (-0.65%)

Closing price 07/18/2025 03:58 PM Eastern

Extended Trading

$3.13 +0.09 (+2.96%)

As of 07/18/2025 07:37 PM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Nano-X Imaging NASDAQ:NNOX

$5.14 +0.07 (+1.38%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$5.22 +0.09 (+1.65%)

As of 06:15 AM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time